Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aglafoline

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aglafoline in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(aglafoline)
Trials
(aglafoline)
Recent Studies (post-2010) (aglafoline)
9,1561875521308

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, TF; Ko, FN; Liou, MJ; Teng, CM; Wu, TS1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aglafoline

ArticleYear
PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
    European journal of pharmacology, 1992, Jul-21, Volume: 218, Issue:1

    Topics: Adenosine Triphosphate; Animals; Benzofurans; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Humans; In Vitro Techniques; Male; Phosphatidylinositols; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Thromboxane B2

1992